首页|Advances in BRAF gene mutations in papillary thyroid carcinoma
Advances in BRAF gene mutations in papillary thyroid carcinoma
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
万方数据
维普
Thyroid cancer is the most common endocrine system tumor. Ultrasound guided fine needle puncture (FNA) can identify benign and malignant thyroid nodules. However, due to the limitation of cytological detection, some thyroid nodules are difficult to distinguish benign and malignant. BRAF gene mutation is a common human oncogenic mutation and the highest mutation frequency in papillary thyroid carcinoma. The combination of FNA and BRAF gene detection can significantly improve the diagnostic rate of benign and malignant thyroid nodules and make up for the deficiency of single diagnosis of cytology. Moreover, while the incidence of thyroid cancer is growing rapidly worldwide, its mortality remains stable. The problem of overdiagnosis and overtreatment of thyroid cancer is becoming more and more obvious. However, due to the limitations of current studies on BRAF genes, its prognostic value for papillary thyroid carcinoma remains controversial. Therefore, in order to reduce the adverse effects of overdiagnosis and treatment, the relationship between gene and tumor biological behavior needs further study in the future.
万方数据
维普
